Recent studies have demonstrated that the MEK/ERK signaling pathway is one of the key regulators of cell growth, survival, and differentiation. But the crucial question is: what role does this pathway play in “self-renewal,” or the ability of hematopoietic stem cells to regenerate?
In this study, human umbilical cord blood stem cells were examined under laboratory conditions. When the activity of the MEK/ERK pathway was blocked with a specific inhibitor, the proliferation of stem cells decreased, although their stemness characteristics (such as the genes HOXB4 and BMI1) were preserved. However, their ability to engraft in vivo was reduced.
On the other hand, the results showed that inhibiting this pathway naturally directed the cells toward erythroid differentiation (the production of red blood cells). The number of new blood colonies increased, and genes promoting blood differentiation (such as TAL1 and GATA2) became more active, while inhibitory genes (such as JUN and PU1) decreased.
In summary, this study demonstrates that the MEK/ERK pathway maintains a delicate balance between proliferation and differentiation of umbilical cord blood stem cells. Moreover, inhibition of this pathway could offer a novel approach for generating red blood cells in regenerative medicine and in the treatment of hematological diseases.
